Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24579293 | 1.00 | CASP3 (0.41) | CASP3KMT2AOPRD1EPHX2NPSR1 | |
| SCHEMBL30861952 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2 | |
| SCHEMBL27197524 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2 | |
| SCHEMBL24579421 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2 | |
| SCHEMBL24579411 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2NPSR1 | |
| SCHEMBL31129073 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2NPSR1 | |
| SCHEMBL30640796 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2NPSR1 | |
| SCHEMBL24579262 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2NPSR1 | |
| SCHEMBL23879137 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2NPSR1 | |
| SCHEMBL30522097 | 0.87 | CASP3 (0.40) | CASP3KMT2AEPHX2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124517-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124517-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | VIP, NPEPPS, ANPEP | CASP3 3884/4885KMT2A 2123/4885OPRD1 3410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.